HK1010737A1 - Novel vehicle gases and their use in medical preparations - Google Patents

Novel vehicle gases and their use in medical preparations

Info

Publication number
HK1010737A1
HK1010737A1 HK98111443A HK98111443A HK1010737A1 HK 1010737 A1 HK1010737 A1 HK 1010737A1 HK 98111443 A HK98111443 A HK 98111443A HK 98111443 A HK98111443 A HK 98111443A HK 1010737 A1 HK1010737 A1 HK 1010737A1
Authority
HK
Hong Kong
Prior art keywords
novel vehicle
medical preparations
vehicle gases
gases
preparations
Prior art date
Application number
HK98111443A
Other languages
English (en)
Inventor
Hans-Hermann Weil
Ottfried Daab
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6399399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010737(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of HK1010737A1 publication Critical patent/HK1010737A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98111443A 1990-02-03 1998-10-21 Novel vehicle gases and their use in medical preparations HK1010737A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4003270A DE4003270A1 (de) 1990-02-03 1990-02-03 Neue treibgase und ihre verwendung in arzneimittelzubereitungen
PCT/EP1991/000178 WO1991011496A1 (de) 1990-02-03 1991-01-31 Neue treibgase und ihre verwendung in arzneimittelzubereitungen

Publications (1)

Publication Number Publication Date
HK1010737A1 true HK1010737A1 (en) 1999-06-25

Family

ID=6399399

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98111443A HK1010737A1 (en) 1990-02-03 1998-10-21 Novel vehicle gases and their use in medical preparations

Country Status (26)

Country Link
US (7) US6419899B1 (cs)
EP (1) EP0513099B1 (cs)
JP (1) JP3497162B2 (cs)
KR (1) KR920703034A (cs)
AT (1) ATE185587T1 (cs)
AU (1) AU656129B2 (cs)
CA (1) CA2075060C (cs)
CZ (1) CZ285209B6 (cs)
DE (2) DE4003270A1 (cs)
DK (1) DK0513099T3 (cs)
ES (1) ES2139574T3 (cs)
FI (1) FI103348B1 (cs)
GR (1) GR3032176T3 (cs)
HK (1) HK1010737A1 (cs)
HR (1) HRP940737B1 (cs)
HU (1) HU218664B (cs)
IL (1) IL97024A0 (cs)
NO (1) NO302420B1 (cs)
NZ (1) NZ236974A (cs)
PT (1) PT96635B (cs)
RU (1) RU2118170C1 (cs)
SI (1) SI9110155B (cs)
SK (1) SK281440B6 (cs)
WO (1) WO1991011496A1 (cs)
YU (1) YU48509B (cs)
ZA (1) ZA91756B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
ES2064160T3 (es) * 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
CA2111002C (en) * 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US5221492A (en) * 1991-08-23 1993-06-22 E. I. Du Pont De Nemours And Company Azeotropic mixture of perfluoropropane and dimethyl ether
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
JP3026841B2 (ja) 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
WO1993011747A1 (en) 1991-12-18 1993-06-24 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
AU3936293A (en) * 1992-03-26 1993-10-21 Great Lakes Chemical Corporation Azeotrope-like compositions of 1,1,1,2,3,3,3-heptafluoropropane and 1,1-difluoroethane
AU680227B2 (en) * 1992-12-09 1997-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
CA2178473C (en) * 1993-12-20 2004-08-24 Tsi-Zong Tzou Flunisolide aerosol formulations
HUT77775A (hu) 1994-12-22 1998-08-28 Astra Aktiebolag Aeroszolformák
US6135628A (en) * 1995-10-13 2000-10-24 Boehringer Ingelheim Pharmceuticals, Inc. Method and apparatus for homogenizing aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
DE19652790A1 (de) * 1996-12-18 1998-06-25 Hermes Fabrik Pharm Praeparate Pharmazeutische Zubereitungen
US6235265B1 (en) * 1998-10-28 2001-05-22 Alliedsignal Inc. Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7273603B2 (en) 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
MXPA06004331A (es) * 2003-10-20 2006-06-05 Schering Corp Composiciones farmaceuticas.
EA013428B1 (ru) * 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
JP2008538758A (ja) * 2005-04-23 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
EP2282418A3 (en) 2009-06-23 2011-03-09 Alcatel Lucent A station comprising at least two transmit antennas, and a method of transmitting therefrom
WO2014100351A2 (en) 2012-12-21 2014-06-26 Map Pharmaceuticals, Inc. 8'-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2490764A (en) * 1945-07-04 1949-12-13 Kinetic Chemicals Inc Fluorinated organic compounds
BE555319A (cs) * 1956-03-21 1900-01-01
BE556587A (cs) 1957-01-31 1957-04-11
GB902590A (en) 1960-03-22 1962-08-01 Allied Chem Production of heptafluoropropane
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
BE629985A (cs) * 1962-11-29
DE1542076A1 (de) * 1966-04-21 1970-03-26 Colgate Palmolive Co Aerosol-Treibmittel
US3369913A (en) * 1967-03-20 1968-02-20 Union Carbide Corp Self-propelling food mixture
DE1719443B2 (de) 1967-10-07 1973-04-05 Suspensions-aerosole und verfahren zu ihrer herstellung
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
FI770215A (cs) 1976-01-30 1977-07-31 Fisons Ltd
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4174795A (en) * 1977-02-14 1979-11-20 Bohm Leslie E Pannier mounting arrangement for cycles
GB2001334B (en) 1977-07-19 1982-03-03 Fisons Ltd Pressurised aerosol formulation
CA1136547A (en) 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
JPS55131096A (en) 1979-03-30 1980-10-11 Daikin Ind Ltd Working fluid for rankine cycle
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
AU7288081A (en) * 1980-07-16 1982-01-21 Glaxo Group Limited 11alpha-amino-androstanes
GB8432063D0 (en) 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
GB8501015D0 (en) 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4778674A (en) * 1986-05-28 1988-10-18 Richardson-Vicks Inc. Dry aerosol foam
DE3735467A1 (de) 1987-10-20 1989-05-03 Bayer Ag Verfahren zur herstellung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen und neue cyclische fluorierte kohlenwasserstoffe, sowie die verwendung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen als treibgas und arbeitsfluessigkeit fuer waermepumpensysteme
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3903336A1 (de) 1989-02-04 1990-08-09 Bayer Ag Verwendung von c(pfeil abwaerts)3(pfeil abwaerts)- bis c(pfeil abwaerts)5(pfeil abwaerts)-polyfluoralkanen als treibgase
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2642738B2 (ja) 1989-04-13 1997-08-20 ライオン株式会社 人体塗布用エアゾール製品
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
NZ243062A (en) 1991-06-10 1993-09-27 Schering Corp Aerosol containing medicament and 1,1,1,2-tetrafluoroethane
CA2111002C (en) 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
ES2089357T3 (es) 1991-12-31 1996-10-01 Hoechst Ag Formulacion medicinal en forma de aerosol.
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
HUT77775A (hu) 1994-12-22 1998-08-28 Astra Aktiebolag Aeroszolformák
EA000889B1 (ru) * 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Дозирующий ингалятор дипропионата беклометазона
WO1998034595A1 (de) 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation

Also Published As

Publication number Publication date
NO923040L (no) 1992-07-31
DE4003270A1 (de) 1991-08-08
ATE185587T1 (de) 1999-10-15
KR920703034A (ko) 1992-12-17
US20020071812A1 (en) 2002-06-13
YU48509B (sh) 1998-09-18
NO923040D0 (no) 1992-07-31
CS9100265A2 (en) 1991-09-15
ES2139574T3 (es) 2000-02-16
NO302420B1 (no) 1998-03-02
WO1991011496A1 (de) 1991-08-08
US20090104127A1 (en) 2009-04-23
SK281440B6 (sk) 2001-03-12
SI9110155A (sl) 1998-04-30
US20040028618A1 (en) 2004-02-12
CA2075060C (en) 2001-01-02
FI103348B (fi) 1999-06-15
SI9110155B (sl) 1999-06-30
PT96635A (pt) 1991-10-31
EP0513099B1 (de) 1999-10-13
FI923491A0 (fi) 1992-08-03
RU2118170C1 (ru) 1998-08-27
DK0513099T3 (da) 2000-04-10
FI923491A (fi) 1992-08-03
FI103348B1 (fi) 1999-06-15
DE59109161D1 (de) 1999-11-18
IL97024A0 (en) 1992-03-29
JP3497162B2 (ja) 2004-02-16
US20070065370A1 (en) 2007-03-22
EP0513099A1 (de) 1992-11-19
JPH05504350A (ja) 1993-07-08
US20110014134A1 (en) 2011-01-20
HU9202508D0 (en) 1992-10-28
US7160538B2 (en) 2007-01-09
PT96635B (pt) 1998-07-31
HUT62455A (en) 1993-05-28
YU15591A (sh) 1994-01-20
NZ236974A (en) 1993-07-27
US6419899B1 (en) 2002-07-16
HU218664B (hu) 2000-10-28
HRP940737B1 (en) 2000-10-31
HRP940737A2 (en) 1997-06-30
AU7211691A (en) 1991-08-21
GR3032176T3 (en) 2000-04-27
CA2075060A1 (en) 1991-08-04
US20050031548A1 (en) 2005-02-10
CZ285209B6 (cs) 1999-06-16
ZA91756B (en) 1992-10-28
AU656129B2 (en) 1995-01-27

Similar Documents

Publication Publication Date Title
GR3032176T3 (en) Novel vehicle gases and their use in medical preparations.
PL297610A1 (cs)
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
HK1028594A1 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
NZ301290A (en) Mycobacterial proteins, micro-organisms producing same and vaccines thereof
EP0587777A4 (en) CARCINOBRYONARY ANTIGEN BINDING PROTEINS AND METHODS OF ISOLATING AND USING THE SAME.
ZA912899B (en) Photocurable self-retainable gel,shaped article prepared therefrom,applications and preparations thereof
DK0439846T4 (da) Biologisk nedbrydelige polymerer, fremgangsmåde til deres fremstilling samt deres anvendelse til depotpræparater med regule
AU2596888A (en) Peptide structures, immunogens containing them and their uses in the control of fertility
AU4324089A (en) Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product
IL110585A0 (en) Tripeptides, their preparation and pharmaceutical compositions containing them
EP0609292A4 (en) Soluble variants of type i membrane proteins, and methods of using them.
AU4174789A (en) Hybrid monoclonal antibodies, their production and use
AU2148192A (en) Cloning and/or expression vectors, preparation and use
AU8628482A (en) Forming iso butane, iso pentane and iso hekane
AU3460597A (en) Mixed nitrogen monoxide gas for medical applications and process for preparing the same
GB2314560B (en) Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
AU2328788A (en) Preparation containing high molecular staphylococcal protein; antibody preparation directed against the protein; and the use of the preparations
EP0596725A3 (en) Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof.
MX9707238A (es) Formulaciones en aerosol de butixocort.
AU630263B2 (en) Liquefied gas metering
AU3724389A (en) Modified rhodomycins, processes for their preparation and their use

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110130